Amplify Weight Loss Drug & Treatment ETF (THNR) Holdings $21.99 +0.08 (+0.37%) As of 04:10 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Top 22 THNR HoldingsRankCompanyCurrent PriceWeightShares Held1LLYEli Lilly and Company$625.15-2.5%12.15%4742NVONovo Nordisk A/S$51.06+4.7%10.43%4,7483REGNRegeneron Pharmaceuticals$563.00+0.6%7.27%3934AMGNAmgen$288.23+1.2%6.93%6905Chugai Pharmaceutical Co., Ltd.N/A6.12%3,9006MRKMerck & Co., Inc.$80.73+0.4%5.16%1,8817ABBVAbbVie$198.10-0.4%5.15%8008PFEPfizer$24.57+1.4%5.13%6,1979GILDGilead Sciences$119.41+8.3%5.03%1,37410Roche Holding AGN/A4.93%45911AZNAstraZeneca$73.56-1.4%4.78%2,05212Innovent Biologics, Inc.N/A4.58%12,00013Shionogi & Co., Ltd.N/A4.16%7,30014CSPC Pharmaceutical Group LimitedN/A4.15%108,00015HIMSHims & Hers Health$51.87+1.6%3.66%2,17516Zealand Pharma A/SN/A2.30%1,22317VKTXViking Therapeutics$37.89+6.6%2.27%2,10518CRNXCrinetics Pharmaceuticals$26.85-3.7%1.86%1,67619Short-Term Investment Trust - Invesco Government & Agency PortfolioN/A1.68%50,02020The United Laboratories International Holdings LimitedN/A1.19%18,00021Hanmi Pharm. Co., Ltd.N/A0.86%12022DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A0.21%82,895,490 Geographic ExposureUnited States69.6%Japan11.5%Cayman Islands5.8%Switzerland5.0%Hong Kong4.7%Denmark2.2%Korea, Republic of0.9%Currency ExposureUSD69.9%JPY11.5%HKD10.5%CHF5.0%DKK2.2%KRW0.9%Sector ExposureHealth Care99.0%Industry ExposureBiotechnology95.1%Health Care Providers & Services3.9%SubIndustry ExposureBiotechnology95.1%Health Care Services3.9% Related Companies and Tools Related Companies ProShares Ultra Nasdaq Cloud Computing ETF Holdings iShares Virtual Work and Life Multisector ETF Holdings KraneShares 100% KWEB Defined Outcome Through January 2026 ETF Holdings Blue Horizon BNE ETF Holdings Tema Luxury ETF Holdings First Trust Bloomberg R&D Leaders ETF Holdings AdvisorShares Hotel ETF Holdings Westwood LBRTY Global Equity ETF Holdings SPDR MSCI USA Climate Paris Aligned ETF Holdings Kelly CRISPR & Gene Editing Technology ETF Holdings This page (NYSEARCA:THNR) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
